The role of the insulin-like growth factor 1 receptor axis in multiple myeloma.
about
The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potentialTherapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma.The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myelomaCancer, physical activity, and exerciseDNA methylation in multiple myeloma is weakly associated with gene transcription.Single-molecule analysis reveals widespread structural variation in multiple myeloma.Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma.The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimeticA peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progressionParadoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma.Fas apoptosis inhibitory molecule is upregulated by IGF-1 signaling and modulates Akt activation and IRF4 expression in multiple myeloma.Widespread deregulation of phosphorylation-based signaling pathways in multiple myeloma cells: opportunities for therapeutic interventionHDAC inhibition synergistically enhances alkylator-induced DNA damage responses and apoptosis in multiple myeloma cells.The effects of forodesine in murine and human multiple myeloma cells.The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancerLack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma.
P2860
Q28075927-C08FDF70-463A-449E-B2E2-821777B412EDQ33934617-245D455C-9E68-4820-AAAB-03AE919AF8D8Q33994341-FD4F8093-5121-4001-938A-CA98397FB622Q34004946-5D1D7AD4-4CEC-4445-9700-E99A5C6A4070Q34534256-A46A7705-D55A-49D3-904A-A6F4DF074169Q35796097-F115D053-7276-4801-BF39-AD13DA91A23DQ38190971-8C1E1BA6-191D-4769-8FAE-3AB33F344731Q38976876-86A2BE1E-F276-4719-8722-642EE40E6A17Q39030703-3E334DFB-D807-4BF8-8790-3D127DFA1CA5Q39158096-F3B205C7-99B2-4508-A373-19F46BC02B36Q39247614-5151F022-3CE7-44D1-88A2-719770CEBC20Q39548450-AA652B76-3E4A-410D-BC5C-796515F0013CQ39706886-0A443E02-2377-472E-B7AE-313286C4801CQ41923743-3EB55C29-4008-4535-94D9-4A9A024F03EEQ42337044-1FEE4F43-8852-440E-9B28-848BA54666FAQ43647817-FC5363C3-BEF3-409F-8D3C-ED3682AD239A
P2860
The role of the insulin-like growth factor 1 receptor axis in multiple myeloma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of the insulin-like growth factor 1 receptor axis in multiple myeloma.
@en
The role of the insulin-like growth factor 1 receptor axis in multiple myeloma.
@nl
type
label
The role of the insulin-like growth factor 1 receptor axis in multiple myeloma.
@en
The role of the insulin-like growth factor 1 receptor axis in multiple myeloma.
@nl
prefLabel
The role of the insulin-like growth factor 1 receptor axis in multiple myeloma.
@en
The role of the insulin-like growth factor 1 receptor axis in multiple myeloma.
@nl
P2093
P2860
P1476
The role of the insulin-like growth factor 1 receptor axis in multiple myeloma.
@en
P2093
Ben van Camp
Eline Menu
Els van Valckenborgh
Karin Vanderkerken
P2860
P356
10.1080/13813450902736583
P577
2009-05-01T00:00:00Z